Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK679586 in Severe Asthma
NCT00843193Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2008
- Primary completion
- Jul 2010
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 2 trial of gsk679586 in asthma, sponsored by GSK. Started Dec 2008; status: completed.
02
Drugs
gsk679586
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00843193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843193.